Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1Plasma cell 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Myelodysplastic Syndromes 65Lymphoma, Non-Hodgkin 51Leukemia, Lymphocytic, Chronic, B-Cell 51Hodgkin Disease 47Leukemia 44Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41Multiple Myeloma 40Lymphoma, Mantle-Cell 37Lymphoma, Follicular 36Myeloproliferative Disorders 34Lymphoma 34Lymphoma, B-Cell, Marginal Zone 33Burkitt Lymphoma 32Lymphoma, Large B-Cell, Diffuse 29Leukemia, Myelomonocytic, Chronic 29Hematologic Neoplasms 25Congenital Abnormalities 24Lymphoma, Large-Cell, Immunoblastic 21Leukemia, Myeloid, Accelerated Phase 21Leukemia, Biphenotypic, Acute 20Primary Myelofibrosis 19Leukemia, Myeloid, Chronic-Phase 19Anemia, Refractory, with Excess of Blasts 19Waldenstrom Macroglobulinemia 18Blast Crisis 17Dendritic Cell Sarcoma, Interdigitating 16Lymphoma, Large-Cell, Anaplastic 15Leukemia, Prolymphocytic 15

Interventions

fludarabine phosphate 5fludarabine 3Busulfan 3Antilymphocyte Serum 3Whole-Body Irradiation 2Mycophenolic Acid 2Cyclophosphamide 2Clofarabine 2Alemtuzumab 2treosulfan 1thymoglobulin 1eltrombopag 1X-Rays 1Thiotepa 1Therapeutics 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Emapalumab 1Cyclosporins 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Bone Marrow Failure Disorders × Whole-Body Irradiation × Clear all
NCT02722668 2025-07-04

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
15 enrolled 15 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Bone Marrow Failure Disorders, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Plasma Cell, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡